CD274 and small cell lung carcinoma: Accordingly, non-tuft cell-derived NE-low SCLC patients show better response to immunotherapy compared to NE-high SCLC patients who exhibit low numbers of immune cells and decreased or absent expression of programmed death-ligand 1 (PD-L1) [1, 39, 40].